262 related articles for article (PubMed ID: 2467947)
21. Treatment of seminoma: does a positive HCG influence prognosis?
Bartsch G; Mikuz G; Frommhold H; Scheiber K
Prog Clin Biol Res; 1985; 203():483-4. PubMed ID: 2421340
[No Abstract] [Full Text] [Related]
22. The value of alpha-fetoprotein and beta-human chorionic gonadotrophin in the management of testicular tumours.
Narayana AS; Loening S; Culp DA
Br J Urol; 1978 Dec; 50(7):605-8. PubMed ID: 88986
[TBL] [Abstract][Full Text] [Related]
23. [Clinical studies of testicular tumor. I. Analysis of 27 patients with seminoma: the clinical significance of hCG-beta determination and of retroperitoneal lymph node dissection for stage I patients].
Tsukamoto T; Kumamoto Y; Ohmura K; Tsunekawa T; Yamazaki K
Hinyokika Kiyo; 1986 Jul; 32(7):989-97. PubMed ID: 2430436
[TBL] [Abstract][Full Text] [Related]
24. [Diagnostic progress in testicular carcinoma].
Aiginger P; Kolbe H; Kühböck J; Spona J
Acta Med Austriaca; 1978; 5(4-5):159-61. PubMed ID: 91300
[TBL] [Abstract][Full Text] [Related]
25. The value of AFP and HCG half lives in predicting the efficacy of combination chemotherapy in patients with non-seminomatous germ cell tumors of the testis.
Willemse PH; Sleijfer DT; Schraffordt Koops H; De Bruijn HW; Oosterhuis JW; Brouwers TM; Ockhuizen T; Marrink J
Oncodev Biol Med; 1981; 2(1-2):129-34. PubMed ID: 6170953
[TBL] [Abstract][Full Text] [Related]
26. Tumor marker levels in post-chemotherapy cystic masses: clinical implications for patients with germ cell tumors.
Beck SD; Patel MI; Sheinfeld J
J Urol; 2004 Jan; 171(1):168-71. PubMed ID: 14665869
[TBL] [Abstract][Full Text] [Related]
27. Recognizing abnormal marker results that do not reflect disease in patients with germ cell tumors.
Morris MJ; Bosl GJ
J Urol; 2000 Mar; 163(3):796-801. PubMed ID: 10687980
[TBL] [Abstract][Full Text] [Related]
28. [The "false positive" tumor marker in malignant testicular tumor].
Bussar-Maatz R; Weissbach L; Dahlmann N; Mann K
Urologe A; 1993 May; 32(3):177-82. PubMed ID: 8511831
[TBL] [Abstract][Full Text] [Related]
29. Serum alpha-fetoprotein and human chorionic gonadotropin as markers for the effect of postoperative radiation therapy and/or chemotherapy in testicular cancer.
Schultz H; Sell A; Nørgaard-Pedersen B; Arends J
Cancer; 1978 Nov; 42(5):2182-6. PubMed ID: 82474
[TBL] [Abstract][Full Text] [Related]
30. Acute changes of alpha-fetoprotein and human chorionic gonadotropin during induction chemotherapy of germ cell tumors.
Vogelzang NJ; Lange PH; Goldman A; Vessela RH; Fraley EE; Kennedy BJ
Cancer Res; 1982 Nov; 42(11):4855-61. PubMed ID: 6181870
[TBL] [Abstract][Full Text] [Related]
31. Lactic dehydrogenase in the monitoring and prognosis of testicular cancer.
Lippert MC; Javadpour N
Cancer; 1981 Nov; 48(10):2274-8. PubMed ID: 6170417
[TBL] [Abstract][Full Text] [Related]
32. [Testis cancer markers. Clinical use].
Salesi N; Di Cocco B; Alghisi F; Calabretta F; Bossone G
Minerva Med; 2002 Oct; 93(5):365-9. PubMed ID: 12410169
[TBL] [Abstract][Full Text] [Related]
33. Diagnostic value of alpha 1-fetoprotein and beta-human chorionic gonadotropin in infancy and childhood.
Schneider DT; Calaminus G; Göbel U
Pediatr Hematol Oncol; 2001; 18(1):11-26. PubMed ID: 11205836
[TBL] [Abstract][Full Text] [Related]
34. [Evaluation of plasma tumor markers in germinal tumors of the testis].
Blacker C; Feinstein MC; Roger M; Zimmer R; Scholler R
Ann Med Interne (Paris); 1984; 135(5):376-80. PubMed ID: 6207755
[TBL] [Abstract][Full Text] [Related]
35. Serial monitoring of serum alpha-fetoprotein and chorionic gonadotropin in males with germ cell tumors.
Thompson DK; Haddow JE
Cancer; 1979 May; 43(5):1820-9. PubMed ID: 87255
[No Abstract] [Full Text] [Related]
36. Serum alpha-fetoprotein and human chorionic gonadotropin in patients with seminoma.
Lange PH; Nochomovitz LE; Rosai J; Fraley EE; Kennedy BJ; Bosl G; Brisbane J; Catalona WJ; Cochran JS; Comisarow RH; Cummings KB; deKernion JB; Einhorn LH; Hakala TR; Jewett M; Moore MR; Scardino PT; Streitz JM
J Urol; 1980 Oct; 124(4):472-8. PubMed ID: 6158584
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of five tumor markers (AFP, CEA, hCG, hPL and SP1) in monitoring therapy and follow-up of patients with testicular germ cell tumors.
Szymendera JJ; Zborzil J; Sikorowa L; Leńko J; Kamińska JA; Gadek A
Oncology; 1983; 40(1):1-10. PubMed ID: 6185897
[TBL] [Abstract][Full Text] [Related]
38. [Studies on the tumor markers in the germinal testicular tumors. Cellular localization of alpha-fetoprotein (AFP), human chorionic gonadotropin (HCG) and carcinoembryonic antigen (CEA) in germinal testicular tumors using an indirect immunoperoxidase method].
Miki T
Nihon Hinyokika Gakkai Zasshi; 1984 Mar; 75(3):503-22. PubMed ID: 6206269
[No Abstract] [Full Text] [Related]
39. [Sterility and tumors of the testis. Study of late exocrine and endocrine functions in stage I or IIA tumors].
Bouchot O; Plougastel ML; Karam G; Bochereau G; Auvigne J
J Urol (Paris); 1989; 95(6):367-71. PubMed ID: 2478640
[TBL] [Abstract][Full Text] [Related]
40. Serum alpha-fetoprotein and human chorionic gonadotropin in the treatment of patients with testicular tumors.
Lange PH; Fraley EE
Urol Clin North Am; 1977 Oct; 4(3):393-406. PubMed ID: 76357
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
